A novel coronavirus (2019-nCoV) has been isolated and considered the causative agent of the cluster of 448 pneumonia cases in the area of Wuhan, Hubei province in China, as well as of the four travel-associated cases in Thailand, Japan and South Korea.
Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and
food are collected annually by the EU Member States (MSs), jointly analysed by EFSA and ECDC and
reported in a yearly EU Summary Report.
This sixth update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas, taking account the latest information available.
This risk assessment evaluates the risk of Ebola virus to EU residents visiting and living in DRC and the risk of importation of the virus into the European Union.
This update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas, taking account of the latest information available.
Since the risk assessment published by ECDC in August 2021 on the risk of vCJD disease transmission via blood and PDMP manufactured from donations obtained in the UK, no new cases of vCJD associated with dietary exposure or transfusion of blood or blood components have been reported in EU/EEA or in the rest of the world.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 August - 2 September and includes updates on Legionnaires’ disease, dengue cases, avian influenza, West Nile virus, COVID-19 and cholera.
This technical report describes the result of a project to provide an overview of the epidemiological situation of WNV and USUV, the diagnostic, surveillance, prevention and control practices applied in EU/EEA countries, and to assess their public health and animal health impact in the EU/EEA.